Yahoo
NSE - Free Realtime Quote INR

Strides Pharma Science Limited (STAR.NS)

1,023.30 -12.60 (-1.22%)
As of 10:27:07 AM GMT+5:30. Market Open.
Chart Range Bar
Loading chart for STAR.NS
  • Previous Close 1,035.90
  • Open 1,033.10
  • Bid 1,020.00 x --
  • Ask 1,020.50 x --
  • Day's Range 1,005.00 - 1,039.90
  • 52 Week Range 768.65 - 1,260.90
  • Volume 44,311
  • Avg. Volume 416,990
  • Market Cap (intraday) 94.32B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 15.80
  • EPS (TTM) 64.57
  • Earnings Date (est.) --
  • Forward Dividend & Yield 5.00 (0.48%)
  • 1y Target Est 1,338.67
  • Moby Rating Neutral

Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment. It also provides branded generics, prescription medicines, and over-the-counter products for infectious diseases, pain management, cardiology, and wellness; and prescription generics for anti-infectives, CNS, cardiovascular, gastroenterology, pain management, and specialty products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

www.strides.com

3,535

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

STAR.NS
13.82%
S&P BSE SENSEX (^BSESN)
5.29%

1-Year Return

STAR.NS
8.08%
S&P BSE SENSEX (^BSESN)
3.01%

3-Year Return

STAR.NS
113.92%
S&P BSE SENSEX (^BSESN)
24.49%

5-Year Return

STAR.NS
87.80%
S&P BSE SENSEX (^BSESN)
33.56%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 14.3B
Earnings --
Profit Margin 0.00%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
5B
10B
0.0%

Analyst Insights

View More

Analyst Price Targets

1,254.00
1,338.67 Average
1,023.30 Current
1,410.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.83%

  • Return on Assets (ttm)

    5.94%

  • Return on Equity (ttm)

    20.31%

  • Revenue (ttm)

    52.13B

  • Net Income Avi to Common (ttm)

    6.17B

  • Diluted EPS (ttm)

    64.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.47B

  • Total Debt/Equity (mrq)

    54.89%

  • Levered Free Cash Flow (ttm)

    -5.68B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: